SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-037961
Filing Date
2022-06-17
Accepted
2022-06-17 17:06:56
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3838
  Complete submission text file 0001209191-22-037961.txt   5373
Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Wilfong Diane E. (Reporting) CIK: 0001374988 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 221024887

Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences